Table 2.
Guidelines | ||||||
---|---|---|---|---|---|---|
Canada | Japan | Norway* | Spain | United Kingdom* | United States (ACOG) | |
Absolute Contraindications: | ||||||
Abnormal amniotic fluid | X | |||||
Bleeding, persistent | 2nd–3rd trimester | X | months 4–9 | X | 2nd–3rd trimester | 2nd–3rd trimester |
CVD | serious | X | X | active CVD, cardiac failure, rheumatic disease | X | hemodynamically significant |
Cerclage, incompetent cervix | X | X | X | X | cervical weakness | X |
Diabetes mellitus | uncontrolled type 1 | |||||
Fetal abnormality | X | |||||
Fetal growth restriction | X | X | ||||
History of fetal growth restriction | X | X | reduce in 2nd–3rd trimester | |||
History of miscarriage, >=3 | X | |||||
History of preterm birth | X | |||||
History of preterm labor | X | reduce in 2nd–3rd trimester | ||||
Hypertonia, poorly controlled | X | |||||
Infectious disease, acute | X | |||||
Lung disease, restrictive | X | X | X | X | ||
Multiple gestation | triplets and higher | X | X | X | X | X |
Placenta previa | symptomatic bleeding | X | X | after 26 weeks | after 26 weeks | |
Preeclampsia, pregnancy induced hypertension | X | X | X | X | X | X |
Premature contractions or labor | X | X | X | X | X | X |
Premature rupture of membranes | X | X | X | X | X | X |
Respiratory disease, serious | X | pulmonary embolism | ||||
Rh+/Rh− immunologic disorder | X | |||||
Systemic disorder, uncontrolled | X | |||||
Thyroid disease, uncontrolled | X | |||||
Thrombophlebitis | X | |||||
Relative Contraindications: | ||||||
Anemia | hemoglobin <100 g/L | or other bleeding disorder | X | severe | hemoglobin <100 g/L | severe |
Arrythmia | X | non-assessed | unevaluated | unevaluated | ||
Bronchitis, chronic | X | X | X | X | ||
Cardiovascular disorder, mild to moderate | X | X | X | |||
Diabetes mellitus | X | poorly controlled | poorly controlled | poorly controlled type 1 | ||
Eating disorder | X | anorexia | X | X | ||
History of extremely sedentary lifestyle | X | X | X | |||
History of fetal growth restriction | X | |||||
History of preterm birth | X | X | ||||
History of preterm labor | X | X | ||||
History of spontaneous abortion | X | |||||
Hypertension | X | X | poorly controlled | poorly controlled | ||
Intrauterine growth restriction | X | X | X | |||
Malnutrition | X | X | X | |||
Multiple gestation, twins | after 28 weeks | |||||
Obesity, morbid (BMI >40 kg/m2) | X | X | X | X | X | |
Orthopedic limitation | X | X | X | |||
Respiratory disorder, mild to moderate | X | X | ||||
Seizures, poorly controlled | epilepsy | X | X | |||
Smoker, current | >20 cigarettes/day | >20 cigarettes/day | heavy smoker | |||
Thyroid disease | X | X | X | poorly controlled | poorly controlled hyperthroidism | |
Underweight, extreme (BMI<12 kg/m2) | extreme thinness | extreme thinness | X |
BMI=body mass index; CVD=cardiovascular diseaes
Distinction between relative and absolute contraindications not made.
Note: The Australia, Denmark, France, and USDHHS guidelines did not include contraindications, as the guidelines were all geared towards healthy women with normal pregnancies.